FDA D.I.S.C.O.: Avelumab in Merkel Cell Carcinoma

Project Oncology® - En podcast af ReachMD

Prøv Mofibo gratis i 30 dage!

Et univers med over 600.000 e- og lydbøger, klik her for at prøve

Kategorier:

FDA medical oncologists discuss the agency’s March 23, 2017 approval of avelumab for the treatment of patients 12 years and older with metastatic Merkel cell carcinoma. Released May 22, 2017

Visit the podcast's native language site